milrinone has been researched along with Liver Dysfunction in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have previously reported that an increase of adenosine 3',5'-cyclic monophosphate (cAMP) in liver tissue after an administration of milrinone, a phosphodiesterase-3 inhibitor attenuates hepatic warm ischemia-reperfusion injury." | 3.75 | Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment. ( Abe, Y; Kume, M; Sato, T; Satoh, K; Takahashi, T; Uchinami, H; Yakubouski, SV; Yamamoto, Y, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satoh, K | 1 |
| Kume, M | 1 |
| Abe, Y | 1 |
| Uchinami, H | 1 |
| Yakubouski, SV | 1 |
| Takahashi, T | 1 |
| Sato, T | 1 |
| Yamamoto, Y | 1 |
1 other study available for milrinone and Liver Dysfunction
| Article | Year |
|---|---|
Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Pressure; Cyclic AMP; Cyclic AMP-D | 2009 |